reports
Availability of Transgene’s 2025 Universal Registration Document (URD...
Availability of Transgene’s 2025 Universal Registration Document (URD) Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2025 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers – AMF) on April 9, 2026, under number D.26-0241. This document, available on the AMF’s website (), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene’s website (...
Mise à disposition du Document d’Enregistrement Universel (DEU) 2025 d...
Mise à disposition du Document d’Enregistrement Universel (DEU) 2025 de Transgene Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies contre le cancer reposant sur des vecteurs viraux, annonce avoir déposé son Document d’Enregistrement Universel 2025 en français, auprès de l’Autorité des Marchés Financiers (AMF) le 9 avril 2026, sous le numéro D.26-0241. Ce document, disponible sur le site internet de l’Autorité des Marchés Financiers (), peut être consulté et téléchargé (au format PDF en français et en anglais et au format ESEF en franç...
Transgene to Participate in Upcoming Investor Meetings
Transgene to Participate in Upcoming Investor Meetings Strasbourg, France, April 7, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of: Investor Access Event (by Allinvest Securities), on April 9, 2026, in Paris (France);Life Sciences Conference (by Van Lanschot Kempen), on April 16, 2026, in Amsterdam (Netherlands). Next financial communications: April 29, 2026: First Quarter 20...
Transgene annonce ses prochaines rencontres avec les investisseurs
Transgene annonce ses prochaines rencontres avec les investisseurs Strasbourg, France, le 7 avril 2026, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies reposant sur des vecteurs viraux contre les cancers, annonce aujourd'hui que son équipe de direction rencontrera des investisseurs institutionnels lors des prochaines éditions de : Investor Access Event (par Allinvest Securities), le 9 avril 2026, à Paris (France) ;Life Sciences Conference (par Van Lanschot Kempen), le 16 avril 2026 à Amsterdam (Pays-Bas). Prochaines commun...
- Ahmed Ben Salem
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
TNG TRANSGENE SA
ENI ENI S.P.A.
REP REPSOL SA
LNZ LENZING AG
CAI CA IMMOBILIEN ANLAGEN AG
ADN1 ADESSO AG
GNFT GENFIT SA
XIL XILAM ANIMATION SA
CPS CYFROWY POLSAT SA
BP. BP P.L.C.
AMAG AMAG AUSTRIA METALL AG
SHEL SHELL PLC
FERGR FERRARI GROUP PUBLIC LIMITED COMPANY
- Ahmed Ben Salem
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
TNG TRANSGENE SA
ENI ENI S.P.A.
REP REPSOL SA
LNZ LENZING AG
CAI CA IMMOBILIEN ANLAGEN AG
ADN1 ADESSO AG
GNFT GENFIT SA
XIL XILAM ANIMATION SA
CPS CYFROWY POLSAT SA
BP. BP P.L.C.
AMAG AMAG AUSTRIA METALL AG
SHEL SHELL PLC
FERGR FERRARI GROUP PUBLIC LIMITED COMPANY
- Martial Descoutures
- Oussema Denguir
- Martial Descoutures
- Oussema Denguir
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps...
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer Strasbourg, France & Schiphol, Netherlands, April 2, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Bio B.V. (“NEC”), a wholly owned subsidiary of NEC Corporation (TSE: 6701), a leader in IT, network and AI technologies, announce the signing of a license agreement to advance the clinical development of TG4050, an individualized neoantigen therapeutic vac...
Transgene et NEC Bio signent un accord de licence pour préparer les pr...
Transgene et NEC Bio signent un accord de licence pour préparer les prochaines étapes de développement de TG4050 dans les cancers de la tête et du cou Strasbourg, France & Schiphol, Pays-Bas, le 2 avril 2026, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies reposant sur des vecteurs viraux contre les cancers, et NEC Bio B.V. (« NEC »), filiale entièrement détenue par NEC Corporation (TSE : 6701), un leader des technologies de l’information, des réseaux et de l’intelligence artificielle (IA), annoncent la signature d’un accor...
- Saïma Hussain
IDI is investing its own money only, with success
IDI is investing its own money only, with success EARNINGS/SALES RELEASES IDI posted quality returns in 2025, expanding its NAV by 8% and adding a good dividend on top. Money back in PE-type investment is a rare event these days. With €222m in dry powder and continued disciplined deployment, the group enters 2026 with serene objectives. IDI is about alignment between its staff’s wealth and its shareholders. We buy into this investment concept. FACT IDI ended the year with NAV per share up +...
- Amira Manai
- Amira Manai
- Emmanuel Matot
- Roy Külter
- Steven Boumans
NK IMERYS SA
LI KLEPIERRE SA
COV COVIVIO SA
GFC GECINA SA
NXI NEXITY SA CLASS A
GYC GRAND CITY PROPERTIES SA
LEI LEIFHEIT AG
MERY MERCIALYS SA
INEA FONCIERE INEA
WHA WERELDHAVE N.V.
BLND BRITISH LAND COMPANY PLC
KOF KAUFMAN & BROAD SA
ALTA ALTAREA SCA
VNA VONOVIA SE
MOBN MOBIMO HOLDING AG
XIOR XIOR STUDENT HOUSING N.V.
ICAD ICADE SA
BYG BIG YELLOW GROUP PLC
UTG UNITE GROUP PLC
IDIP INSTITUT DE DEVELOPPEMENT INDUSTRIEL SCA
COFB COFINIMMO SA
CAI CA IMMOBILIEN ANLAGEN AG
TEG TAG IMMOBILIEN AG
VASTB VASTNED RETAIL BELGIUM NV
ALLN ALLREAL HOLDING AG
KOMN KOMAX HOLDING AG
PSPN PSP SWISS PROPERTY AG
UBS UBM DEVELOPMENT AG
SPSN SWISS PRIME SITE AG
PAT PATRIZIA AG
MONT MONTEA SCA
AED AEDIFICA SA
CARM CARMILA SAS
LEG LEG IMMOBILIEN AG
IRES IRISH RESIDENTIAL PROPERTIES REIT PLC
CPINV CARE PROPERTY INVEST SA
SAFE SAFESTORE HOLDINGS PLC
ARG ARGAN SA
VGP VGP NV
COL INMOBILIARIA COLONIAL SOCIMI SA
DIC DIC ASSET AG
MERLIN MERLIN PROPERTIES SOCIMI S.A.
IREN INVESTIS HOLDING SA
SRE SIRIUS REAL ESTATE LIMITED
HOME NEINOR HOMES SA
AT1 AROUNDTOWN SA
LAND LAND SECURITIES GROUP PLC
MVC METROVACESA SA
IGD IMMOBILIARE GRANDE DISTRIBUZIONE SIIQ S.P.A.
NSI NSI N.V.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
INS INSTONE REAL ESTATE GROUP AG
AEDAS AEDAS HOMES SA
WDP WAREHOUSES DE PAUW SCA
ECMPA EUROCOMMERCIAL PROPERTIES NV
ALAFY AFYREN
CTPNV CTP NV
SHUR SHURGARD SELF STORAGE LIMITED
4X0 STEYR MOTORS AG
IS INTERSHOP HOLDING AG
- Emmanuel Matot
- Roy Külter
- Steven Boumans
NK IMERYS SA
LI KLEPIERRE SA
COV COVIVIO SA
GFC GECINA SA
NXI NEXITY SA CLASS A
GYC GRAND CITY PROPERTIES SA
LEI LEIFHEIT AG
MERY MERCIALYS SA
INEA FONCIERE INEA
WHA WERELDHAVE N.V.
BLND BRITISH LAND COMPANY PLC
VETO VETOQUINOL SA
KOF KAUFMAN & BROAD SA
ALTA ALTAREA SCA
VNA VONOVIA SE
MOBN MOBIMO HOLDING AG
XIOR XIOR STUDENT HOUSING N.V.
ICAD ICADE SA
BYG BIG YELLOW GROUP PLC
UTG UNITE GROUP PLC
IDIP INSTITUT DE DEVELOPPEMENT INDUSTRIEL SCA
COFB COFINIMMO SA
CAI CA IMMOBILIEN ANLAGEN AG
TEG TAG IMMOBILIEN AG
VASTB VASTNED RETAIL BELGIUM NV
ALLN ALLREAL HOLDING AG
KOMN KOMAX HOLDING AG
PSPN PSP SWISS PROPERTY AG
UBS UBM DEVELOPMENT AG
SPSN SWISS PRIME SITE AG
PAT PATRIZIA AG
MONT MONTEA SCA
AED AEDIFICA SA
CARM CARMILA SAS
LEG LEG IMMOBILIEN AG
IRES IRISH RESIDENTIAL PROPERTIES REIT PLC
CPINV CARE PROPERTY INVEST SA
SAFE SAFESTORE HOLDINGS PLC
ARG ARGAN SA
VGP VGP NV
COL INMOBILIARIA COLONIAL SOCIMI SA
DIC DIC ASSET AG
MERLIN MERLIN PROPERTIES SOCIMI S.A.
IREN INVESTIS HOLDING SA
SRE SIRIUS REAL ESTATE LIMITED
HOME NEINOR HOMES SA
AT1 AROUNDTOWN SA
LAND LAND SECURITIES GROUP PLC
MVC METROVACESA SA
IGD IMMOBILIARE GRANDE DISTRIBUZIONE SIIQ S.P.A.
NSI NSI N.V.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
INS INSTONE REAL ESTATE GROUP AG
AEDAS AEDAS HOMES SA
WDP WAREHOUSES DE PAUW SCA
ECMPA EUROCOMMERCIAL PROPERTIES NV
ALAFY AFYREN
CTPNV CTP NV
SHUR SHURGARD SELF STORAGE LIMITED
4X0 STEYR MOTORS AG
IS INTERSHOP HOLDING AG
Transgene to Deliver an Oral Presentation on its Individualized Neoant...
Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress Strasbourg, France, March 26, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced a 30-minute oral presentation on TG4050, the Company’s Individualized Neoantigen Therapeutic Vaccine (INTV) at the World Vaccine Congress (WVC), taking place from March 31 to April 2, 2026, in Washington, D.C., USA. The presentation will be held on April 1st. Th...
Transgene présentera son vaccin thérapeutique individualisé TG4050 au...
Transgene présentera son vaccin thérapeutique individualisé TG4050 au World Vaccine Congress Strasbourg, France, le 26 mars 2026, 17h45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies reposant sur des vecteurs viraux contre les cancers, annonce que son Vaccin Thérapeutique Individualisé reposant sur des Néoantigènes (VTIN), TG4050, fera l’objet d’une présentation orale de 30 minutes à la conférence annuelle World Vaccine Congress, à Washington D.C., (États-Unis), du 31 mars au 2 avril 2026. La présentation aura lieu le 1er avril. ...
- Jean-François Granjon
- Margaux van Oerle
- Jean-François Granjon
- Margaux van Oerle
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.